Abstract: A compound comprising a ligand LA comprising a moiety L having a structure of Formula I is provided. In Formula I, LA coordinated to a metal M; A1 is selected from B, N, P, P?O, P?S, Al, Ga, SiR?, GeR?, and SnR?; where rings A, B, and C are 5- or 6-membered rings; Y1, Y2, and Y3 are selected from direct bonds, the metal M, and a variety of linkers; a+b+c=2 or 3; and one of a number of specific conditions is met. OLED devices, consumer products, and formulations including the compound are also provided.

Abstract: A compound including a ligand LA of Formula I is disclosed.

Abstract: A composition is disclosed that includes a first compound capable of functioning as a host in an emissive layer of an OLED at room temperature; and a second compound that includes a ligand LA of Formula III where ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring; where R represents two adjacent substituents that are joined together to form a ring that is fused to ring B, and R has a structure of Formula IV or Formula V disclosed herein.

Abstract: Provided are organometallic compounds including a ligand LA of Formula I: Also provided are formulations including these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: A compound including a first ligand LX of Formula II is disclosed, where F is a 5-membered or 6-membered carbocyclic or heterocyclic ring; each RF and RG independently represents mono to the maximum possible number of substitutions, or no substitution; Z3 and Z4 are each independently C or N and coordinated to a metal M to form a 5-membered chelate ring; G is a fused ring structure comprising five or more fused heterocyclic or carbocyclic rings, of which at least one ring is of Formula III the fused heterocyclic or carbocyclic rings in the fused ring structure G are 5-membered or 6-membered; of which if two or more 5-membered rings are present, at least two of the 5-membered rings are fused to one another; Y can be one of BR?, NR?, PR?, O, S, Se, C?O, S?O, SO2, CR?R?, SiR?R?, and GeR?R?; the metal M can be coordinated to other ligands; and the ligand LX can be linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand.

Abstract: A compound having a ligand LA of Formula I, is disclosed. In Formula I, ring B is a 5-membered or 6-membered ring; K is a direct bond, O, or S; X is O, S, Se, NR, CRR?, SiRR?, or GeRR?; R1 and R2 are each independently selected from a variety of substituents; each R, R?, RA, and RB is independently hydrogen or a substituent; LA is coordinated to a metal M selected from Os, Ir, Pd, Pt, Cu, Ag, or Au by the dashed lines; any two adjacent of R1, R2, R, R?, RA, or RB can be joined or fused to form a ring, with the proviso that when ring B is a 6-membered ring, two RB substituents are not joined to form a fused 6-membered aromatic ring. Organic light emitting devices, consumer products, formulations, and chemical structures containing the compounds are also disclosed.

Abstract: Provided are organometallic compounds having a structure of Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: Provided are organometallic compounds having a ligand LA of Formula I: Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: A compound comprising a ligand LA coordinated to a metal M, the ligand LA selected from the group consisting of Formula I, Formula II, and Formula III ring A is a 5- or 6-membered carbocyclic or heterocyclic ring; wherein ring A of Formula I connects to ring B at X1, X2, or X3 to form a five-membered chelate ring with the metal; Z1 and Z2 are independently selected from C or N; and X1 to X10 are independently selected from C or N. An organic light emitting device (OLED) comprising an anode, a cathode and an organic layer disposed between the anode and the cathode, the organic layer comprising a compound selected from Formula I, Formula II, or Formula III, and a consumer product comprising the OLED.

Abstract: Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: A compound comprising a first ligand LA of Formula I, is disclosed. In the structure of Formula I, ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring; Z1-Z4 are each independently C or N; at least two consecutive Z1-Z4 are C, and are fused to a structure of Formula II or Formula III Y1; Y1 and Y2 are each independently O, S, Se, CRR?, SiRR?, or GeRR?; each RA, RB, RC, R, and R? is a hydrogen or a substituent; and any two substituents may be joined or fused together to form a ring. In the compound, LA is complexed to a metal M by the dashed lines in Formula I to form a five-membered chelate ring, and M has an atomic weight greater than 40. Organic light emitting devices and consumer products containing the compounds are also disclosed.

Abstract: A compound comprising a ligand LA of Formula I, where G has a structure of is disclosed. In ligand LA, Ring C is a 5-membered or 6-membered ring; K is a direct bond, O, or S; when K is O or S, X6 is C; each of RA, RB, and RC is H or a substituent, and can be joined together to form a ring; each of X1 to X6 is independently C or N; X1 is C if it is connected to ring C; the RB substituents of at least two adjacent ones of X2 to X5 are joined to form a ring; and the ligand LA is complexed to Ir through the two indicated dash lines to form a 5-membered chelate ring. Organic light emitting devices, consumer products, formulations, and chemical structures containing the compounds are also disclosed.

Abstract: Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: A compound including a first ligand LA of Formula I is disclosed.

Abstract: The present disclosure is directed to cyclometalated metal compounds containing novel ligands having unique fused rings. The inventive compounds are expected to exhibit unique photophysical and electronic properties and are useful in an organic electroluminescence device to improve the performance.

Abstract: A compound of the formula MLALB where ligand LA is of Formula I, and ligand LB is of Formula II below. M is selected from Os(II) or Ru(II), and the compound MLALB has a formal neutral charge; and rings A, B, C, D, E, and F are independently a 5-membered or 6-membered aromatic ring, and RA, RB, RC, RD, RE,and RF each independently represent mono to the maximum allowable substitution, or no substitution. L1, L2, L3, and L4 independently represent a single bond or an organic linking group; W1, W2, W3, and W4 are independently selected from carbon or nitrogen; Y1, Y2, Y3, and Y4 are independently selected from carbon or nitrogen; and Z1, Z2, and Z3 are independently selected from carbon or nitrogen, and at least one of Z1, Z2, and Z3 is nitrogen. An organic electroluminescent device that includes an anode, a cathode, and an organic layer comprising a compound of the formula MLALB where ligand LA is of Formula I, and ligand LB is of Formula II above.

Abstract: A compound comprising a ligand LA coordinated to a metal M wherein ring A, ring T, and ring W are independently selected from a 5-membered or 6-membered heterocyclic or carbocyclic ring, and the ring W is fused to the ring T. The metal compounds having a ligand LA can be found in an OLED that includes an organic layer positioned between an anode and a cathode where the organic layer comprises a metal compound above having a ligand LA disclosed herein. We also describe a consumer product comprising the OLED.

Abstract: A compound comprising a first bidentate ligand LA, wherein LA comprises a structure of Formula I; wherein Z is selected from the group consisting of O, S, NR, BR, CRKRL, C?CRKRL, SiRKRL, —CRKRLCRMRN—, —SiRKRLSiRMRN—, —CRKRLO—, —SiRKRLO—, and —CRK?CRL—; wherein ring A, ring B, and ring C are each independently a 5-membered carbocyclic ring, 5-membered heterocyclic ring, 6-membered carbocyclic ring or 6-membered heterocyclic ring; wherein LA is coordinated to a metal M forming a 5-membered chelate ring; wherein M is selected from the group consisting of Ir, Pt, Pd, Ru, Rh, Os, Re, Cu, Ag, and Au; wherein RA, RB, and RC each represent mono to the maximum allowable substitution, or no substitution; wherein each R, RK, RL, RM, RN, RA, RB, and RC is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, selenyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, a

Abstract: Provided are compounds of formula Ir(LA)2LC where: each ligand LA can be the same or different and has Formula I Also provided are formulations comprising these iridium complexes comprising pyridine-azole ligands. Further provided are OLEDs and related consumer products that utilize these iridium complexes comprising pyridine-azole ligands.

Abstract: An OLED including an anode, a cathode, and an organic layer between the anode and the cathode, where the organic layer includes a compound having the formula [LA]3-nIr[LB]n is disclosed.